US Stock MarketDetailed Quotes
ACRV Acrivon Therapeutics
- 7.520
- +0.170+2.31%
Close Nov 27 16:00 ET
- 7.890
- +0.370+4.92%
Post 20:01 ET
234.14MMarket Cap-2827P/E (TTM)
7.700High7.210Low51.14KVolume7.460Open7.350Pre Close383.66KTurnover0.47%Turnover RatioLossP/E (Static)31.14MShares11.90052wk High1.19P/B81.83MFloat Cap3.19052wk Low--Dividend TTM10.88MShs Float25.470Historical High--Div YieldTTM6.67%Amplitude3.190Historical Low7.501Avg Price1Lot Size
Acrivon Therapeutics Stock Forum
Sign in to post a comment
$Acrivon Therapeutics (ACRV.US)$ Acrivon Therapeutics Price Target Raised to $30.00/Share From $26.00 by Piper Sandler
Dow Jones· 2 mins ago
Dow Jones· 2 mins ago
4
$Cidara Therapeutics (CDTX.US)$ $Acrivon Therapeutics (ACRV.US)$ Same people trading both? Hehehe charts look very similar. At least as i post this! Hehehe
1
6
$Acrivon Therapeutics (ACRV.US)$ Acrivon Therapeutics: Acr-2316, a Potential First-in-Class Dual Wee1/Pkmyt1 Inhibitor, Ind Timeline Accelerated With Filing Now Expected in Q3 2024
$Acrivon Therapeutics (ACRV.US)$ Acrivon Therapeutics: A 50% Confirmed Overall Response Rate Showed With Acr-368 in Oncosignature-Positive Gynecological (Ovarian, Endometrial) Cancers
2
$Acrivon Therapeutics (ACRV.US)$
NEWS
Acrivon Therapeutics to Host Corporate R&D Event Highlighting AP3 and Pipeline Progress, Including Ongoing Prospective Validation of ACR-368 OncoSignature with Initial Phase 2 Data for ACR-368, and Preclinical Progress for ACR-2316
WATERTOWN, Mass., April 16, 2024 (GLOBE NEWSWIRE) -- Acrivon Therapeutics, Inc. (“Acrivon” or “Acrivon Therapeutics”) (Nasdaq: ACRV), a clinical stage biopharmaceutical company developing precision oncology medicines that it matche...
NEWS
Acrivon Therapeutics to Host Corporate R&D Event Highlighting AP3 and Pipeline Progress, Including Ongoing Prospective Validation of ACR-368 OncoSignature with Initial Phase 2 Data for ACR-368, and Preclinical Progress for ACR-2316
WATERTOWN, Mass., April 16, 2024 (GLOBE NEWSWIRE) -- Acrivon Therapeutics, Inc. (“Acrivon” or “Acrivon Therapeutics”) (Nasdaq: ACRV), a clinical stage biopharmaceutical company developing precision oncology medicines that it matche...
1
$Acrivon Therapeutics (ACRV.US)$
NEWS
Acrivon Therapeutics Presents Data at AACR Annual Meeting Highlighting the Capabilities of Acrivon Predictive Precision Proteomics (AP3) for the Discovery of ACR-2316, a Novel, Selective WEE1/PKMYT1 Inhibitor, and the Identification of Actionable Resistance Mechanisms to ACR-368
Acrivon Therapeutics, Inc. announced data from two posters presented at the AACR Annual Meeting. ACR-2316, a dual WEE1/PKMYT1 inhibitor, showed potent anticancer activity in preclin...
NEWS
Acrivon Therapeutics Presents Data at AACR Annual Meeting Highlighting the Capabilities of Acrivon Predictive Precision Proteomics (AP3) for the Discovery of ACR-2316, a Novel, Selective WEE1/PKMYT1 Inhibitor, and the Identification of Actionable Resistance Mechanisms to ACR-368
Acrivon Therapeutics, Inc. announced data from two posters presented at the AACR Annual Meeting. ACR-2316, a dual WEE1/PKMYT1 inhibitor, showed potent anticancer activity in preclin...
1
Acrivon Therapeutics Secures $130 Million in Private Placement Financing: A Leap Forward in Cancer Treatment Innovation.
In an era where the battle against cancer continues to demand innovative solutions, Acrivon Therapeutics has taken a significant step forward by securing $130 million through private placement financing. This move not only underscores the biotech industry's confidence in Acrivon's pote...
In an era where the battle against cancer continues to demand innovative solutions, Acrivon Therapeutics has taken a significant step forward by securing $130 million through private placement financing. This move not only underscores the biotech industry's confidence in Acrivon's pote...
2
No comment yet
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
JESSE JAMES8832 : i expeced so much better for this
JESSE JAMES8832 : maybe fill that gap to 6.62?
Trytosaveabit OP JESSE JAMES8832 : Yup! But look at PCSA! It gets just a PT increase and flyin! This gets great news and a PT increase and dud? Hehehe
Trytosaveabit OP JESSE JAMES8832 : It might try?